DMAC·25253X207·US·equity·Healthcare - Biotechnology-13D/G
DMAC (DIAMEDICA THERAPEUTICS INC) is held by 60 institutional investors as of Q1 2026. Largest holders: COOPERMAN LEON G ($13.7M), BlackRock, Inc. ($12.6M), MILLENNIUM MANAGEMENT LLC ($6.3M). Net institutional sentiment: Mixed.
See how DMAC's score breaks down across 4 SEC sources
Showing 1-20 of 69
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer